RNOH launches national cancer service
The Royal National Orthopaedic Hospital NHS Trust (RNOH) has launched a national service to treat patients suffering from blood cancer that affects the spine.
The launch, at The Royal College of Surgeons, saw national and international speakers covering a range of topics on new treatment approaches for multiple myeloma and conventional and interventional management for myeloma spinal disease.
The RNOH's myeloma service, which is led by Mr Sean Molloy, consultant orthopaedic surgeon, and Dr Charalampia Kyriakou, consultant haematologist, will accept national referrals and offer advice to other units on how to treat patients.
Mr Sean Molloy said the launch comes after he and Dr Kyriakou developed international guidelines for the treatment of myeloma spinal disease.
"The service has been running locally at the RNOH for four years now, and on the back of our experience we were asked by the International Myeloma Committee to write up-to-date guidelines, which will influence the national service we are embarking upon and they will be published over the next few months," he said.
"Myeloma commonly affects the spine and in up to 70% of patients it causes spinal fractures. The myeloma service will provide a one-stop clinic for diagnostics and management. It will be a multi-disciplinary approach with spinal surgeons, haematologists, pain management consultants and therapists."
The service has the potential to promote cross fertilisation of different cancer disciplines and will provide a link to other specialities such as bone, breast and vertebral disease
For further information about the service, please visit the Myeloma pages.